Where does BioFire Diagnostics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioFire Diagnostics, LLC ranks #10,875 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioFire Diagnostics, LLC hold?

BioFire Diagnostics, LLC holds 28 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is BioFire Diagnostics, LLC's Innovation Score?

BioFire Diagnostics, LLC has an Innovation Score of 37.4 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is BioFire Diagnostics, LLC's patent grant rate increasing or decreasing?

BioFire Diagnostics, LLC's recent grant velocity is +36% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for BioFire Diagnostics, LLC's patents?

BioFire Diagnostics, LLC's patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioFire Diagnostics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioFire Diagnostics, LLC

Q: What technology areas does BioFire Diagnostics, LLC focus on?

BioFire Diagnostics, LLC's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 25 patents, ranking #182 of 2,502 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 28 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biofire ranks #10,875 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 11 technology areas.

#10,875
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.4/100): 15.6
avg claims per patent: +36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10875 · US Corporation #10,875 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #10,875/49,997
PHOTO-FINISH Battelle Savannah…
CPC-FOCUS C12Q · 11 areas
INNOV-THIN 37.4/100
CLAIMS-RICH 15.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Battelle Savannah River Alliance, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biofire’s 37.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (31%) Velocity 4.7 pts (13%) Breadth 11.7 pts (31%) Claim depth 9.4 pts (25%)

Qualcomm Incorporated · highest

85
BioFire Diagnostics · this assignee

37
IlluminOss Medical · near

37
Ocean's King… · near

37
Pactiv · near

37
Seeo · near

37
3D Lighting… · lowest

7

What this shows Biofire's Innovation Score is 37.4/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biofire?

Each dot is one of Biofire’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biofire’s own 15.6 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biofire vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biofire's grants concentrate

BioFire Diagnostics, LLC is a focused PatentsView assignee: 11 CPC subclasses with 89.3% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2017. By volume, Biofire sits between Battelle Savannah River Alliance, LLC and Blue Buffalo Enterpises, Inc..

Biofire's three-year grant acceleration

BioFire Diagnostics, LLC shows 7 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Battelle Savannah…

28
Bebop Sensors

28
Belron Internatio…

28
Bench Tree Group

28
Bioness

28
Bitvore

28
Blakely Ventures

28
Blue Buffalo Ente…

28
Biofire Diagnosti… ◀

28

What this shows BioFire holds 28 patents at rank #10,876, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioFire

By rank, the assignees closest to #10,876 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in BioFire's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for BioFire, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), BioFire ranks #182 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Pactiv LLC 37 IlluminOss Medical, Inc. 37 Seeo, Inc. 37 Ocean's King Lighting Science & Technology Co., Ltd. 37

Biofire's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

BioFire Diagnostics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	10.7%
2016	2	7.1%
2017	1	3.6%
2018	3	10.7%
2019	2	7.1%
2020	1	3.6%
2021	7	25.0%
2022	2	7.1%
2023	2	7.1%
2024	3	10.7%
2025partial year	2	7.1%

Which technologies does BioFire Diagnostics, LLC patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 25

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 17

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioFire Diagnostics, LLC's patent record in context - here's where to go next.

BioFire Diagnostics, LLC's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 89.3% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #10,875 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioFire Diagnostics, LLC against Battelle Savannah River Alliance, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.